MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with O

Ozanimod

Ozanimod 230microgram capsules

No stability information

Stability notes for Ozanimod 230microgram capsules

There are no stability notes for this medicine.

Supplier

Zeposia 0.23mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)

Ozanimod 230microgram capsules and Ozanimod 460microgram capsules

No stability information

Stability notes for Ozanimod 230microgram capsules and Ozanimod 460microgram capsules

There are no stability notes for this medicine.

Supplier

Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd)

Ozanimod 460microgram capsules

No stability information

Stability notes for Ozanimod 460microgram capsules

There are no stability notes for this medicine.

Supplier

Zeposia 0.46mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)

Ozanimod 920microgram capsules

No stability information

Stability notes for Ozanimod 920microgram capsules

There are no stability notes for this medicine.

Supplier

Zeposia 0.92mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.